Medical Weight Loss for New Iberia, Louisiana Residents

New Iberia, Louisiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving New Iberia through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Flexible payment for New Iberia residents: we accept HSA, FSA, Klarna, and Affirm, so paying for your Louisiana telehealth program can fit your budget. Medication is billed separately. Doctor review just $119 (medication separate).

Why New Iberia Residents Choose New Hope Weight Loss

We are built for people who would rather not deal with insurance at all. New Hope is cash-pay friendly, so there are no prior authorizations, no denials, and no waiting on a carrier to decide what you are allowed to try. Patients in New Iberia pay a flat physician fee of $119 and a clear monthly medication price, and we accept HSA, FSA, Klarna, and Affirm so the cost can fit your budget without a fight.

Medical weight loss for New Iberia is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

From the first visit to your refills, people in New Iberia, Louisiana are cared for by Dr. Sharma through telehealth, so the only thing missing is the commute to Costa Mesa. We care for patients throughout downtown New Iberia and the Acadiana region of Iberia Parish. Wherever you live in Louisiana, your medication ships straight to your door in discreet packaging, so the same care reaches you whether you are in New Iberia proper or one of the surrounding downtown New Iberia and the Acadiana region of Iberia Parish.

Whether you live in central New Iberia or out toward the edges of Louisiana, you see the same physician, Dr. Anjmun Sharma, and pay the same flat pricing with no distance surcharge. If you and Dr. Sharma decide tirzepatide fits your goals, New Iberia patients can begin from $233 per month, billed apart from your initial $119 visit. From one end of Louisiana to the other, New Hope Weight Loss provides physician-supervised GLP-1 care by telehealth from our Costa Mesa, California clinic, with no need to visit in person.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives New Iberia patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for New Iberia

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across New Iberia. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your New Iberia address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, New Iberia

Where is the closest New Hope Weight Loss to New Iberia?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because New Iberia, Louisiana patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from New Iberia?

It is not. We run a complete telehealth model, so people in New Iberia handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to New Iberia using cold-pack insulation that keeps it stable until it reaches you.

What should a New Iberia patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and New Iberia patients are not charged any extra distance fee.

What areas of New Iberia do you serve?

We serve patients from across New Iberia by telehealth, including downtown New Iberia and the Acadiana region of Iberia Parish.

What does treatment cost for New Iberia patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for New Iberia.

New Iberia Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving New Iberia, Louisiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.